Investors

Top

Investor relations

We use innovative science to pursue novel treatments that address important medical challenges in neurological, autoimmune and rare diseases. Our therapies for multiple sclerosis and haemophilia are just the beginning.

Science that truly matters

 

Biogen is more focused than ever on the areas where we can have the greatest impact. We built our business by putting science and patients at the centre of every decision and investment we make.

Review our 2014 performance

Stock information

Find Biogen’s current and historical stock information. 

NASDAQ: BIIB (Common Stock)

  • Volume
  • Today's Open $
  • Previous Close $
  • 52 Week High $
  • 52 Week Low $